Ï㽶ÊÓƵ

Home / Chercheurs et partenaires / Chercheurs∙euses D2R

Maureen McKeague

Academic title(s): 

Assistant Professor

Maureen McKeague
Branch: 
Université McGill
Department: 
Chimie
Pharmacologie et thérapeutique
Areas of expertise: 
  • aptamers
  • ribozymes
  • transcription factors
  • leukemia
  • riboswitches
Biography: 

Prof. Maureen McKeague received her PhD in Chemistry from Carleton University, then conducted postdoctoral research at Stanford University and ETH Zurich. She is currently an Assistant Professor with a dual appointment in the Departments of Chemistry and Pharmacology & Therapeutics.

Prof. McKeague’s interdisciplinary research group is developing nucleic acid tools to treat and characterize blood diseases. Achievements include the development of encodable Ï㽶ÊÓƵ switches for non-invasive drug monitoring in cells and live animals (Nat Commun 2019, Chemical Science 2023), innovating robust diagnostics for detecting viruses and malaria, and discovering oligonucleotide therapeutics for leukemia targets (Cell Reports Medicine 2023, Leukemia 2024).
Prof. McKeague’s leadership in nucleic acid research has been recognized with a Canada Research Chair, Kavli Foundation Emerging Researcher Award, and Cole Foundation Transition Award. She is the Vice-President of the International Society on Aptamers and Associate Editor for the Molecular Therapy Nucleic Acids.

Link(s): 
Projects: 

D2R Projects

Co-Investigator

Foundational Projects (Cycle 1): McGill Brand mÏ㽶ÊÓƵ Production
Foundational Projects (Cycle 1): Ï㽶ÊÓƵ-targeting therapeutics to address antimicrobial resistance
Back to top